BrUOG 337: Olaparib Prior to Radical Prostatectomy For Patients With Locally Advanced Prostate Cancer and Defects in DNA Repair Genes
Phase of Trial: Phase II
Latest Information Update: 31 May 2018
At a glance
- Drugs Olaparib (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 May 2018 Status changed from not yet recruiting to recruiting.
- 22 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Apr 2018.